NCT04624841View on ClinicalTrials.gov

Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis

PHASE4UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

January 15, 2022

Conditions
Acute CholecystitisAcute; Cholecystitis, CholedocholithiasisAcute Cholecystitis With Obstruction
Interventions
DRUG

Indocyanine Green

2.5-7.5 mg (0.05 mg/kg) injection

Trial Locations (1)

3050

Hamad General Hospital, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT04624841 - Indocyanine Green to Visualize Critical View of Safety During Laparoscopic Cholecystectomy for Acute Cholecystitis | Biotech Hunter | Biotech Hunter